GLP-1 receptor agonists and coagonists now offer us another tool for obesity management.
Treatment of clozapineassociated obesity and diabetes with exenatide in adults with schizophrenia: a randomized controlled trial (CODEX)
In a study of healthy men, Amarasates mode of action was confirmed as being a potent stimulant of endogenous production of gut hormones, including GLP-1, CCK, and PYY.1 Taken an hour before a meal, this nutraceutical increased basal levels of GLP-1 and CCK to six times above baseline, and to twice the typical release occurring after eating (Figure 1).1 Moreover, Amarasate enhanced the release of GLP-1 and other hormones in the same physiological pattern seen normally
Online-only programs may be convenient, but many patients prefer a clinic where they can speak with a provider, ask questions, and receive care in person
When that delayed edible finally kicks in, hunger can show up strong even if your stomach fills quickly, which creates a strange disconnect where food sounds amazing but your body taps out fast
Other options include hydroxychloroquine, sulfasalazine, and leflunomide